25 April 2025 – World DNA Day

By: Dr. Lee Pey Yee & Ahmad Termidzi Mohd Azhar
๐ก Have you ever wondered what makes you unique? The answer lies in your DNAโthe extraordinary blueprint made up of three billion letters that define how you grow, how you look, and how your body works.
DNA Day commemorates two landmark scientific achievements: the ๐๐ข๐ฌ๐๐จ๐ฏ๐๐ซ๐ฒ ๐จ๐ ๐ญ๐ก๐ ๐๐๐ ๐๐จ๐ฎ๐๐ฅ๐ ๐ก๐๐ฅ๐ข๐ฑ ๐ฌ๐ญ๐ซ๐ฎ๐๐ญ๐ฎ๐ซ๐ ๐๐ฒ ๐๐๐ฆ๐๐ฌ ๐๐๐ญ๐ฌ๐จ๐ง ๐๐ง๐ ๐ ๐ซ๐๐ง๐๐ข๐ฌ ๐๐ซ๐ข๐๐ค ๐ข๐ง ๐๐๐๐, and the completion of the ๐๐ฎ๐ฆ๐๐ง ๐๐๐ง๐จ๐ฆ๐ ๐๐ซ๐จ๐ฃ๐๐๐ญ ๐ข๐ง ๐๐๐๐. These breakthroughs have revolutionised our understanding of genes and opened new frontiers in biomedical research. The interesting part is that ๐ก๐ฎ๐ฆ๐๐ง๐ฌ ๐ฌ๐ก๐๐ซ๐ ๐ฆ๐จ๐ซ๐ ๐ญ๐ก๐๐ง ๐๐% ๐จ๐ ๐ญ๐ก๐๐ข๐ซ ๐๐๐, yet these minor variations within our genetic code that make each of us unique, be it in the way we look, or how we respond to the world around us.
Today, DNA plays a crucial role in modern medicine. It helps doctors make more precise decisions, enables scientists to better understand diseases, and allows individuals to explore their ancestry. Though small in size, this molecule has a profound impact on our lives.
๐๐๐ฌ๐๐๐ซ๐๐ก ๐๐ข๐ ๐ก๐ฅ๐ข๐ ๐ก๐ญ๐ฌ ๐๐ซ๐จ๐ฆ ๐๐๐๐
UMBI continues to lead high-impact DNA research, translating genomic discoveries into practical healthcare solutions aligned with precision medicine and national priorities.
๐ฌ ๐๐๐ง๐๐๐ซ ๐๐๐ง๐จ๐ฆ๐ข๐๐ฌ
- UMBI leverages next-generation sequencing (NGS) and advanced bioinformatics to identify genetic drivers of cancer and treatment response. Current focus areas include biomarker discovery and druggable mutations to enable early detection and targeted therapies.
๐ฌ ๐๐จ๐ง-๐๐จ๐ฆ๐ฆ๐ฎ๐ง๐ข๐๐๐๐ฅ๐ ๐๐ข๐ฌ๐๐๐ฌ๐๐ฌ (๐๐๐๐ฌ)
- Through genome-wide association studies (GWAS) and epigenetic profiling, UMBI investigates genetic and environmental factors underlying chronic diseases such as cardiovascular disease and diabetes, with emphasis on population-specific risks.
๐ฌ ๐๐ข๐๐ซ๐จ๐๐ข๐จ๐ฆ๐ ๐๐๐ฌ๐๐๐ซ๐๐ก
- Research on the human microbiome is uncovering how microbial communities influence diseases, including cancer and metabolic conditions. These insights are driving the development of microbiome-based biomarkers and preventive strategies.
๐ฌ ๐๐จ๐ฉ๐ฎ๐ฅ๐๐ญ๐ข๐จ๐ง-๐๐๐ฌ๐๐ ๐๐๐ฌ๐๐๐ซ๐๐ก
- The Malaysian Cohort Project is a large-scale population study involving over 100,000 participants, contributing to the development of a national-scale biobank and big data resource. This initiative integrates genomic, lifestyle, and environmental data to better understand disease patterns among Malaysians. Insights from this cohort support risk prediction, early detection, and the advancement of precision public health strategies tailored to Malaysiaโs diverse population. [More on The Malaysian Cohort Project]
๐ฌ ๐๐ก๐ ๐๐๐ฅ๐๐ฒ๐ฌ๐ข๐๐ง ๐๐๐ง๐ ๐๐ง๐จ๐ฆ๐
- Building on whole-genome sequencing of 4,000 individuals from 56 Malaysian sub-ethnic groups, UMBI has developed and launched the Malaysian Pangenome to better capture the countryโs genetic diversity. This initiative aims to improve the accuracy of genetic studies, enhance disease risk prediction, and ensure that precision medicine approaches are more inclusive and relevant to local populations. [Watch The Malaysian Pangenome Multimedia]
This DNA Day, take a moment to appreciate the science within youโsimple, powerful, and uniquely yours.
Happy DNA Day!
—–
SDG 3 | SDG 4 | SDG 8 | SDG 16 | SDG 17 – Health/Wellbeing, Education, Quality of life, Global partnership.